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Chemoprevention is a relatively novel and promising approach for controlling cancer that uses speciﬁc natural products or
synthetic agents to suppress, reverse, or prevent premalignancy before transformationinto invasive cancer. Oral cavity squamous
cell carcinoma (OCSCC) represents a large, worldwide health burden with approximately 274,000 cases diagnosed annually
worldwide. Smoking and alcohol consumption are major inducers of OCSCC. Recently, the human papilloma virus was also
shown to potentially be an etiologic factor. Due to its easily identiﬁable risk factors and the presence of premalignant regions, oral
cancer makes a good candidate for chemoprevention. Green tea is the most widely consumed beverage in the world, and it has
received considerable attention because of its abundant, scientiﬁcally proven, beneﬁcial eﬀects on human health. In this review,
we discuss the role of green tea in oral cancer chemoprevention with regard to the multiple molecular mechanisms proposed in
v a r i o u si nv i t r o ,i nv i v o ,a n dc l i n i c a lt r i a l s .
1.Introduction
Oral squamous cell carcinoma represents a large, worldwide
health burden as the eleventh most common cancer type
with approximately 274,000cases diagnosed annually world-
wide [1, 2]. Carcinogenesis is a multistage process consisting
of initiation, promotion, and progression phases [3]. Thus,
the multistage sequence of events has many phases for
prevention and intervention. Despite therapeutic advances
in this disease, OCSCC is associated with severe morbidity
with a 5-year overall survival rate of less than 50% [4]a n d
a high occurrence of second primary tumors (20% to 30%)
[5–7]. The overall 5-year survival rate of OCSCC has not
signiﬁcantly improved in the past 30 years [2]. Smoking and
alcohol consumption are major inducers of OCSCC. The
prevalence of OCSCC in smokers is 4–7 times higher than in
nonsmokers, andif alcoholor chewing tobaccoisaugmented
tothecigaretteusage,theincidenceofOCSCCisincreasedby
19-and 123-fold, respectively [8]. In recent years, thehuman
papilloma virus (HPV), particularly HPV type 16, has also
been suggested as an etiologic factor for OCSCC, especially
among younger patients who are nonsmokers with no or
minimal alcohol consumption [9, 10]. Patients diagnosed
with OCSCCwho havebeen continually exposed to smoking
and alcohol are at a high risk for recurrences and second
primary tumors (SPTs) [2].
Chemoprevention, a notion introduced by Sporn et al.
[11], is the use of natural products or synthetic chemicals for
the reversal, suppression, or prevention of the premalignant
transformation of cells to a malignant form. In this respect,
13-cis- retinoic acid has been reported to be eﬀective in
the prevention of transformation of oral leukoplakia and
dysplasia [12] and to stop the development of second pri-
mary tumors in patients with head and neck squamous cell
carcinoma [5, 6]. However, critical problems with retinoids
include toxicity and the recurrence of the leukoplakia after2 ISRN Oncology
the cessation of treatment [12]. Thus, the investigation for a
better chemopreventive agent is warranted.
An ideal chemopreventive agent must have (i) little or
no toxicity, (ii) a high eﬃcacy in multiple sites, (iii) the
capability for oral consumption, (iv) a known mechanism
of action, (v) low cost, and (vi) human acceptance [13].
Currently, natural products, especially the antioxidants
present in common food and beverages, have obtained
great attention for cancer prevention owing to their various
health beneﬁts, noticeable lack of toxicity/side eﬀects, and
the limitations of other chemotherapeutic agents [14].
Several studies have shown that natural products composed
of a wide spectrum of biologically active phytochemicals,
including phenolics, ﬂavonoids, carotenoids, alkaloids, and
nitrogen, suppress the early and late stages of carcinogenesis
[15].
Green tea is the most widely consumed beverage in the
world and is especially popular in the Far East. Because of its
abundant, scientiﬁcally proven, beneﬁcial eﬀects on human
health, green tea has received considerable attention [16].
The polyphenols found in green tea have been documented
to inhibit a variety of processes associated with cancer cell
growth, survival, and metastasis [17].
Here, we highlight the evidence of green tea’s role in oral
cancer chemoprevention with regard to multiple molecular
mechanismsproposedinvariousinvitro,invivo,andclinical
trials.
2.GreenTea andPolyphenols
Green teas are derived from Camellia sinensis and represent
the most consumed beverages in the world, next to water
[18]. Green tea contains polyphenols, glycosides, leucoan-
thocyanins, and phenol acid [19], with the polyphenols
constituting 36% of the fresh green tea leaf dry weight [20].
In a randomized controlled trial (RCT), green tea was
documented to signiﬁcantly reduce the level of total serum
cholesterol and low density lipoprotein (LDL) cholesterol
in the green tea group, which was treated with 150mg
green tea catechins and 150mg of other tea polyphenols
ad a yf o r3m o n t h s[ 21]. A meta-analysis showed that an
increase in tea consumption of three cups (711mL/day)
decreased the risk of a myocardial infarction by 11% [22].
Epidemiological studies have also shown that the intake of
greenteamayreducetheriskofmalignancy[23,24].In1997,
Imai and colleagues published a prospective cohort survey
of more than 8,552 Japanese individuals that demonstrated
the ingestion of more than 10 daily cups (120mL each)
of green tea decreased the development of cancer [25].
Additionally, in 2009, Myung and colleagues performed a
meta-analysis of epidemiologic studies that found green
tea consumption to have a preventative eﬀect on stomach
cancer [26]. Seely et al. also reported that green tea con-
sumptionmaypossiblyhelppreventbreastcancerrecurrence
in early-stage (I and II) cancers [27]. In many mouse
skin tumor models, protection against UVB-induced skin
carcinogenesis and the inﬂammatory response was obtained
with topical application or oral consumption of green tea
[28–31].
Green tea contains four major polyphenols: epicatechin
(EC), epigallocatechin (EGC), epicatechin-3-gallate (ECG),
and epigallocatechin-3-gallate (EGCG), composing 1–3%,
3–6%, 3–6%, and 7–13%, respectively, of the fresh green tea
leaf dry weight [20, 32]. Numerous studies have reported
that green tea polyphenols have plentiful beneﬁcial eﬀects
on human health, including not only having antiviral, anti-
inﬂammatory, and antiallergic eﬀects, but also aiding in
weight control [33, 34]. It has also been documented that
polyphenols inhibit tumorigenesis in a variety of organs,
including skin, lung, oral cavity, esophagus, stomach, small
intestine, colon, liver, pancreas, ovary, and mammary gland
[35–39].
The polyphenol EGCG has speciﬁcally been documented
to have chemopreventive eﬀects against various cancers [40–
45], and one cup of green tea holds 200mg of EGCG
[46]. EGCG has been reported to have multiple biologic
functions, including preventing the formation of blood ves-
sels (angiogenesis) and organizing blood vessel permeability
to hinder the blood supply to cancerous cells [47, 48].
Adding EGCG to cells leads to decreased phosphorylation
of the epidermal growth factor receptor (EGFR), Akt, and
Stat3, without regulating protein levels [44, 49]. EGCG has
also been shown to inhibit telomerase activity and lead
to telomerase fragmentation [50]. Green tea polyphenols
regulate multiple points controlling cancer cell growth,
survival, and metastasis, with eﬀects at the DNA, RNA, and
protein levels [18].
Desirable green tea ingestion is known to be 3 to 5
cups per day (up to 1200mL/day), providing a minimum of
250mg/day catechins [51].
3.The ChemopreventiveEffectof
Green TeaPolyphenolsonOralCancer:
In Vitro Studies
Numerous in vitro studies have shown the antiproliferative
eﬀectandapoptosisinducingcapabilityofgreenteapolyphe-
nols in oral cancer cell lines. Jeﬀrey et al. have reported
that the antiproliferative eﬀects of green tea polyphenols
and EGCG were more noticeable towards oral cancer cell
lines (CAL27, HSC-2, and HSG1) than normal ﬁbroblasts
(GN56 and HGF-1) [52]. The application of EGCG to
cell culture medium resulted in the formation of hydrogen
peroxide. This result was consistent with EGCG performing
as a pro-oxidant because tumor cells are known to be
more vulnerable to oxidative forces than normal cells [52,
53]. An in vitro, multistage tumorigenesis model for oral
cancer showed that cell proliferation was arrested at all
stages of carcinogenesis by EGCG with the best eﬃcacy
demonstrated in dysplastic cells [54]. A study by Masuda
andcoworkers[49]dem ons trat edthattr eatm entwithEGCG
increased the proportion of cells in the G1 phase of the
cell cycle and induced apoptosis. Moreover, in cells treated
with EGCG, a reduction in the cyclin D1 protein and in the
hyperphosphorylated form of pRB was observed [49]. Liu
et al. showed that green tea extract and epigallocatechin-3
gallate inhibited the growth of 3 squamous cell lines (CAL-
27, SCC-25, and KB) via S and G2/M phase arrest. TheISRN Oncology 3
major signaling cascades inﬂuenced by green tea extract
and EGCG were shown to be the EGFR and Notch path-
w a y s ,w h i c hi nt u r n ,a ﬀected cell-cycle-related networks
[55].
Hsu et al. reported that treatment of caspase 3 wild-type
oral carcinoma cell lines with EGCG resulted in a gradual
decrease of mitochondrial function down to an insigniﬁcant
level, but caspase 3 null cells did not undergo apopto-
sis. This result demonstrates that green tea polyphenol-
associated apoptosis is mitochondria targeted and caspase 3
dependent [56]. EGCG was also found by cDNA microarray
to upregulate p21WAF1 in the OSC2 oral cancer cell
line, which may facilitate caspase 3-mediated apoptosis
[57].
The overexpression of HER-2 (neu/erbB2) is correlated
with a poor prognosis in patients with breast cancer
or oral squamous cell carcinoma, presumably due to an
increased metastatic ability and resistance to various cancer
chemotherapies [58, 59]. Masuda et al. [45]r e p o r t e dt h a t
treatment of head and neck squamous cell carcinoma
cell lines (HNSCC) (YCU-H891, YCU-N861) with EGCG
resulted in a 50% inhibition of growth and a marked
inhibition of HER-2 phosphorylation. This outcome was
connected with the prevention of Stat3 activation as well
as the inhibition of c-fos and cyclin D1 promoter activity.
Recent studies have also demonstrated that RECK methyla-
tion is associated with enhancing metastasis and invasion in
human cancers [60–62].
Chen et al. illustrated that the invasion, motility, migra-
tion, and secretion of MMP-2 and u-PA in SCC-9 oral
cancer cells, through attenuation of p-FAK and p-Src,
could be signiﬁcantly inhibited by epigallocatechin-3 gallate
[63]. Long et al. reported that hypermethylation of the
RECK gene is associated with a poor prognosis in oral
squamous cell carcinoma [64]. A study by Kato et al.
showed the treatment of oral cancer cells with EGCG
partially reversed the hypermethylation status of the RECK
gene and signiﬁcantly increased the expression level of
RECK mRNA [65]. EGCG was also found to reduce the
expression of MMP-2 and MMP-9 [16, 65]. Taken together,
these outcomes demonstrate that green tea polyphenols may
reduce the invasion and migration of human oral cancer
cells.
The concept of combination chemoprevention pursues
the ability to enhance the chemopreventive eﬃcacy of
both agents (synergism), while reducing side eﬀects by
dose reduction. Synergistic interactions were shown between
beta-carotene and alpha-tocopherol in an in vivo hamster
cheek pouch tumorigenesis model [66] as well as between
beta-carotene and anticancer alkylating agents in an in
vitro study that utilized tongue squamous carcinoma cells
[67]. Khaﬁf et al. documented an interactive synergistic
eﬀect of EGCG and curcumin treatment. Speciﬁcally, EGCG
arrested malignant human oral epithelial cells in G1,w h e r e a s
curcumin blocked cells in S/G2M[ 68]. The potency of
the cytotoxic and apoptotic eﬀects on human tongue
squamous carcinoma cells was greater with a combination
of lacroferrin and tea polyphenols than with polyphenols
alone [69]. A study by Amin et al. showed that EGCG
and erlotinib (epidermal growth factor receptor tyrosine
kinase inhibitor) had a synergistic growth-inhibitory eﬀect
in a nude mouse xenograft model of squamous cell
carcinomas of the head and neck via inhibition of the
nuclear factor-κB signaling pathway [70]. EGCG was found
to protect normal salivary gland cells from the eﬀects
of gamma irradiation and the chemotherapy drug cis-
platinum(II)diammine dichloride (CDDP), suggesting that
the combination of green tea consumption with chemother-
apy or radiotherapy could be a promising avenue of treat-
ment [71].
4.The ChemopreventiveEffectof
Green TeaPolyphenolsonOralCancer:
In Vivo Studies
Experimental carcinogenesis models are valuable tools to
investigate the multistep characteristics of carcinogenesis
and to study various modulations that intervene in the
development of cancer. These models also have many
advantages over simple in vivo studies. The hamster buccal
pouch carcinogenesis model (HBP) has been extensively
employed to investigate the chemopreventive eﬀectiveness
of medical plants and dietary agents [72]. Treatment with
7,12-dimethylbenz[a]anthracene(DMBA)inducedHBPcar-
cinoma and upregulated genotoxicity. Inhibition of DMBA-
induced HBP carcinomas by green tea polyphenols was
observed, and polyphenol treatment was associated with
a signiﬁcant reduction in phase I enzymes, regulation of
lipid peroxidation, and increased antioxidant and phase II
enzyme activities in this model [73]. DMBA-induced oral
carcinogenesis was arrested by EGCG in hamsters showing
a lower risk of dysplasia and oral carcinoma [74]. 4-
nitroquinoline 1-oxide (4-NQO) is also known to induce
multistep carcinogenesis [75]. Srinivasan et al. reported
a signiﬁcant reduction in the number of tumors, tumor
volume, and oral squamous cell carcinomas in green
tea polyphenol treated rats relative to 4-NQO induced
animals. Additionally, application of green tea polyphe-
nols in this study was shown to enhance the activity
of phase II enzymes (glutathione-S-transferase and UDP-
glucuronyl transferase) and reduce the activity phase I
enzymes (cytochrome b5, cytochrome P450, cytochrome
b5 reductase, cytochrome P450 reductase, aryl hydrocarbon
hydroxylase, and DT-diaphorase) [76]. EGCG was also
suﬃcienttostopphorbol-12-myristate-induced cellinvasion
and matrix metalloproteinase-9 expression, as demonstrated
by the inhibition of tumor growth observed with EGCG
treatment in SCC-9 cells in vivo via a cancer cell xenograft
nude mouse model [63].
Recent studies have also reported that amyloid precursor
protein (APP) is upregulated in pancreatic cancer cells and
SW837 colon carcinoma cells both in vitro and in vivo
[77, 78]. Ko et al. demonstrated that APP was signiﬁcantly
upregulated in MBN-induced HBP carcinomas but was
signiﬁcantly decreased by tea intake [79]. Moreover, APP
expression and secretion from oral squamous cell carcinoma
was arrested by the application of green tea polyphenols in a
dose-dependent manner [79].4 ISRN Oncology
5.The ChemopreventiveEffectofGreen Tea
PolyphenolsonOral Cancer:ClinicalTrials
and aProspectiveCohortStudy
Schwartz et al. performed a pilot study in which green
tea total extracts (2000–2500mg/day) were administrated in
d r i n k i n gw a t e rt os m o k e r sf o rf o u rw e e k s[ 80]. The study
found that during the course of green tea administration,
smoking-inducedDNAdamagewasreduced,cellgrowthwas
inhibited, the percentage of cells in S phase was decreased,
cells accumulated in G1 phase, DNA content became more
diploid and less aneuploid, and markers of apoptosis were
upregulated [80]. A double-blind intervention trial was
performed in patients with oral mucosa leukoplakia using
mixed tea extracts [81]. After 6 months, the oral leuko-
plakia was reduced in size in 40% of the patients who
ingested tea extracts. In a phase II randomized, placebo-
controlled clinical trial of green tea extract (500, 750,
or 1,000mg/m2) in high risk oral premalignant lesions
(OPL), the OPL clinical response rate was higher in all
green tea extract (GTE) arms versus placebo but did not
reach statistical signiﬁcance [82]. However, higher-dose GTE
arms displayed higher responses and demonstrated a dose-
dependent eﬀect [82]. Moreover, stromal VEGF and cyclin
D1 expressions were reduced in clinically responsive GTE
patients and increased in nonresponsive patients at 12 weeks
[82].
Ide and colleagues conducted a prospective nationwide,
large-scale cohort study in Japan. A total of 20,550 men
and 29,671 women aged 40–79 years without any history of
oral cancer were included [83]. During a mean follow-up
period of 10.3 years, 37 oral cancer cases were identiﬁed.
For women, the hazard ratios (HRs) of oral cancer for
a green tea consumption of 1-2, 3-4, or 5 or more cups
per day, were 0.51, 0.60, and 0.31, respectively, when
compared with individuals who drank less than one cup
per day. However, for men, no such trends were identiﬁed
[83].
6.Conclusion
This paper summarized the chemopreventive eﬃcacy of
green tea polyphenols in various in vitro and in vivo oral
cancer models. All in vitro and in vivo studies demonstrated
that green tea can regulate numerous molecular pathways
involvedin cancerpromotionand progression. The epidemi-
ology and multistep carcinogenesis of oral cancer suggests
that it is a preventable cancer. Prevention is the most ideal
strategy to save lives and reduce the morbidity of radical
surgery. Although small trials have shown promising results,
chemoprevention clinical trials with green tea performed
in oral cancer are very limited. Substantial clinical trials
are required to investigate the chemopreventive eﬀectiveness
of green tea polyphenols against oral cancer either alone
or in combination with other chemopreventive agents. To
seek a fundamental association between the consumption of
green tea and a reduced rate of oral cancer development or
mortality,more randomizedclinicaltrials (RCTs)andcohort
studies are needed.
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